SEC 13F Intelligence

Managers / Q1 2019 · view latest →

MASO CAPITAL PARTNERS Ltd

CIK 0001698093 · 8/F PRINTING HOUSE, 6 DUDDELL STREET, HONG KONG, 000000 · 852 34686200

Reported Value
$145M
Q1 2019
Positions
16
Filings on Record
30
2019–present window
Filed
May 14, 2019
original filing

Summary

Maso Capital Partners Ltd reported $145M in U.S.-listed holdings across 16 positions for Q1 2019.

Its largest position, Bemis, represents 18.0% of the portfolio.

Compared with Q4 2018, the fund opened 8 new positions and exited 2.

Portfolio Metrics

Turnover
+24.6%
vs prior filed quarter
Top-10 Concentration
+83.0%
share of reported value
Largest Position
+18.0%
Bemis
New / Exited
8 / 2
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $80MQ4 ’18Q1 ’19: $145MQ2 ’19: $191MQ3 ’19: $278MQ4 ’19: $311MQ4 ’19Q1 ’20: $386MQ2 ’20: $248MQ3 ’20: $179MQ4 ’20: $367MQ4 ’20Q1 ’21: $260MQ2 ’21: $304MQ3 ’21: $222MQ4 ’21: $218MQ4 ’21Q1 ’22: $246MQ2 ’22: $177MQ3 ’22: $429MQ1 ’23: $150,581Q1 ’23Q2 ’23: $228,000Q3 ’23: $183,560Q4 ’23: $115,713Q1 ’24: $135,260Q1 ’24Q3 ’24: $107MQ4 ’24: $79MQ1 ’25: $66MQ2 ’25: $57MQ2 ’25Q3 ’25: $61Mfilingsflow.com

Portfolio Composition

By security type
Other: 45.4%Common Stock: 40.5%ADR: 14.1%
  • Other · 45.4% · $66M
  • Common Stock · 40.5% · $59M
  • ADR · 14.1% · $20M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2018 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BEMIS CO INCNEW+472.8K472.8K+$26M$26M
RHT1EURRED HAT INCNEW+119.0K119.0K+$22M$22M
CELGCELGENE CORPNEW+167.5K167.5K+$16M$16M
ALIBABA GROUP HLDG LTDNEW+77.0K77.0K+$14M$14M
GDS HLDGS LTDNEW+3.00M3.00M+$3M$3M
MELCO RESORTS AND ENTMT LTDNEW+120.0K120.0K+$3M$3M
TAKEDA PHARMACEUTICAL CO LTDNEW+129.4K129.4K+$3M$3M
SESEA LTDNEW+71.4K71.4K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2019

15 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1BEMIS CO INCCOM18.03%$26M472.8K
2RHT1EURRED HAT INChistory →COM14.95%$22M119.0K
3CELGCELGENE CORPhistory →COM10.86%$16M167.5K
4CHINA BIOLOGIC PRODS HLDGS ICOM10.32%$15M164.5K
5GNWGENWORTH FINL INChistory →COM CL A7.05%$10M2.68M
6CYOUUSDCHANGYOU COM LTDhistory →ADS REP CL A5.90%$9M502.3K
7YUMCYUM CHINA HLDGS INChistory →COM5.50%$8M178.0K
8BUNGE LIMITEDCOM4.90%$7M134.3K
9SOHUSOHU COM LTDhistory →SPONSORED ADS3.36%$5M294.5K
10ACHCACADIA HEALTHCARE COMPANY INhistory →COM2.18%$3M108.2K
11GDS HLDGS LTDDEBT 2.000% 6/02.01%$3M3.00M
12MELCO RESORTS AND ENTMT LTDADR1.86%$3M120.0K
13TAKEDA PHARMACEUTICAL CO LTDSPONSORED ADS1.81%$3M129.4K
14SESEA LTDhistory →SPONSORED ADS1.15%$2M71.4K
15NAKED BRAND GROUP LIMITEDORD SHS0.46%$667,0002.12M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$61M44Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$57M29Aug 18, 202513F-HRchanges · EDGAR ↗
Q1 2025$66M34May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$79M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$107M36Nov 4, 202413F-HRchanges · EDGAR ↗
Q2 2024Under review28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$135,26036May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$115,71327Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$183,56037Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$228,00037Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$150,58136May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review42Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022REVEALED$429M60Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$177M61Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$246M56May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$218M47Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M41Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$304M54Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$260M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$367M45Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$179M21Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$248M22Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$386M21May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$311M20Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$278M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$191M19Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$145M16May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$80M10Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.